3 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 122 points (0.7%) at 17,066 as of Monday, July 14, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,069 issues advancing vs. 930 declining with 155 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.5%. Top gainers within the industry include Grifols ( GRFS), up 2.4%, Cigna ( CI), up 1.6%, Abbott Laboratories ( ABT), up 1.0% and Aetna ( AET), up 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Edwards Lifesciences ( EW) is one of the companies pushing the Health Services industry lower today. As of noon trading, Edwards Lifesciences is down $1.44 (-1.6%) to $86.50 on light volume. Thus far, 366,794 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $86.38-$88.34 after having opened the day at $88.34 as compared to the previous trading day's close of $87.94.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $9.3 billion and is part of the health care sector. Shares are up 33.7% year-to-date as of the close of trading on Friday. Currently there are 10 analysts that rate Edwards Lifesciences a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Edwards Lifesciences Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Stryker Corporation ( SYK) is down $0.65 (-0.8%) to $83.37 on light volume. Thus far, 499,419 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $83.28-$84.49 after having opened the day at $84.40 as compared to the previous trading day's close of $84.02.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $31.7 billion and is part of the health care sector. Shares are up 11.8% year-to-date as of the close of trading on Friday. Currently there are 14 analysts that rate Stryker Corporation a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Boston Scientific ( BSX) is down $0.14 (-1.0%) to $13.16 on light volume. Thus far, 3.6 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 12.3 million shares. The stock has ranged in price between $13.12-$13.34 after having opened the day at $13.34 as compared to the previous trading day's close of $13.29.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Boston Scientific has a market cap of $17.3 billion and is part of the health care sector. Shares are up 10.6% year-to-date as of the close of trading on Friday. Currently there are 12 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%